XENE position history
The shares of Xenon Pharmaceuticals (XENE) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 406,535 shares, $6.2M, 1.6% of portfolio
- 2021 Q4: 402,667 shares, $13M, 3.2% of portfolio, Reduce −1.0%
- 2022 Q1: 380,163 shares, $12M, 3.0% of portfolio, Reduce −5.6%
- 2022 Q2: 438,623 shares, $13M, 3.6% of portfolio, Add +15.4%
- 2022 Q3: 375,223 shares, $14M, 3.6% of portfolio, Reduce −14.5%
- 2022 Q4: 316,092 shares, $12M, 3.5% of portfolio, Reduce −15.8%
- 2023 Q1: 316,092 shares, $11M, 3.4% of portfolio
- 2023 Q2: 280,538 shares, $11M, 3.0% of portfolio, Reduce −11.2%
- 2023 Q3: 280,538 shares, $9.6M, 3.0% of portfolio
- 2023 Q4: 276,739 shares, $13M, 3.1% of portfolio, Reduce −1.4%
- 2024 Q1: 273,739 shares, $12M, 2.7% of portfolio, Reduce −1.1%
- 2024 Q2: 273,739 shares, $11M, 2.5% of portfolio
- 2024 Q3: 273,739 shares, $11M, 2.5% of portfolio
- 2024 Q4: 273,739 shares, $11M, 2.7% of portfolio
- 2025 Q1: 273,739 shares, $9.2M, 2.6% of portfolio
- 2025 Q2: 287,939 shares, $9M, 2.5% of portfolio, Add +5.2%
- 2025 Q3: 287,939 shares, $12M, 2.9% of portfolio
- 2025 Q4: 287,939 shares, $13M, 3.0% of portfolio
- 2026 Q1: 250,772 shares, $15M, 3.3% of portfolio, Reduce −12.9%
- 2026 Q2: 250,772 shares, $15M, 2.9% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|